Presymptom Health Secures £1.5 Million to Revolutionize Sepsis Detection with artificial intelligence
Presymptom Health, a groundbreaking UK-based startup utilizing artificial intelligence (ai) for early infection and sepsis detection, has secured £1.5 million in equity and grant funding to combat the life-threatening consequences of delayed sepsis diagnosis. This investment comes as a critical response to the alarming statistics surrounding sepsis, which claims nearly 48,000 lives annually in Britain alone (UK Sepsis Trust).
The Danger of Delayed Diagnosis
Sepsis, a severe and potentially life-threatening response to infection, continues to claim countless lives due to delayed diagnosis. The condition’s lethality is directly linked to late detection. For every hour sepsis goes untreated, the mortality rate increases by 10%, emphasizing the importance of early intervention for successful treatment (Mayo Clinic).
Presymptom Health: Saving Lives with ai
CEO of Presymptom Health, Dr Iain Miller, spoke passionately about the deadly consequences of delayed sepsis diagnosis: “Sepsis diagnostics have remained stagnant for over a century. Regrettably, doctors can only diagnose it once advanced symptoms and organ failure become apparent – which is often too late.” Presymptom Health’s innovative technology has the potential to detect infection and sepsis “up to three days before formal clinical diagnosis,” offering an essential window for effective treatment.
Unlocking the Power of ai in Biobanks
Presymptom Health’s technology harnesses machine learning and advanced ai analytics to extract vital insights from an extensive biobank. By analyzing these samples, the company’s technology enables substantially faster detection of infections and sepsis.
Revolutionizing the Medical Field: ai Saves Lives
The recent funding round for Presymptom Health follows the trend of ai’s transformative impact on the medical field. In August, 24Bitcoin reported on a study conducted in Sweden that highlighted the potential for ai to significantly enhance breast cancer detection rates in screenings (EurekAlert!).
Breast Cancer: A Global Crisis
Breast cancer reportedly claimed approximately 670,000 lives worldwide in 2022, with an estimated 42,250 women predicted to succumb to the disease in 2024 (American Cancer Society). This tragic statistic further underscores the importance of leveraging ai and advanced technologies for earlier and more accurate cancer detection.
Investors Recognize the Potential
The funding round attracted prominent investors, including UKI2S, Ploughshare, and MedTechToMarket. These investments reflect a growing recognition of the potential for ai to revolutionize various industries and save lives.
In conclusion, Presymptom Health’s groundbreaking advancements in sepsis detection through the use of ai represents a significant step forward for both healthcare and the lives of countless individuals. As ai continues to make its mark on various fields, the potential for saving lives and revolutionizing industries is increasingly apparent.
